Abstract:Type I and III interferons (IFNs) are essential for antiviral immunity and act through two different but complimentary pathways. First, IFNs activate intracellular antimicrobial programs by triggering the upregulation of a broad repertoire of viral restriction factors. Second, IFNs activate innate and adaptive immunity. Dysregulation of IFN production can lead to severe immune system dysfunction. It is thus crucial to identify and characterize the cellular sources of IFNs, their effects, and their regulation to promote their beneficial effects and limit their detrimental effects, which can depend on the nature of the infected or diseased tissues, as we will discuss. Plasmacytoid dendritic cells (pDCs) can produce large amounts of all IFN subtypes during viral infection. pDCs are resistant to infection by many different viruses, thus inhibiting the immune evasion mechanisms of viruses that target IFN production or their downstream responses. Therefore, pDCs are considered essential for the control of viral infections and the establishment of protective immunity. A thorough bibliographical survey showed that, in most viral infections, despite being major IFN producers, pDCs are actually dispensable for host resistance, which is achieved by multiple IFN sources depending on the tissue. Moreover, primary innate and adaptive antiviral immune responses are only transiently affected in the absence of pDCs. More surprisingly, pDCs and their IFNs can be detrimental in some viral infections or autoimmune diseases. This makes the conservation of pDCs during vertebrate evolution an enigma and thus raises outstanding questions about their role not only in viral infections but also in other diseases and under physiological conditions.

Pivotal Functions of Plasmacytoid Dendritic Cells in Systemic Autoimmune Pathogenesis.

Advance in roles of plasmacytoid dendritic cells in viral infection immunity

Predominant Role of Plasmacytoid Dendritic Cells in Stimulating Systemic Autoimmunity.

Innate immune functions of plasmacytoid dendritic cells.

Ontogeny and Function of Plasmacytoid Dendritic Cells

Plasmacytoid Dendritic Cells: Sensing Nucleic Acids in Viral Infection and Autoimmune Diseases

Distinct Roles of Myeloid and Plasmacytoid Dendritic Cells in Systemic Lupus Erythematosus

Plasmacytoid Dendritic Cells and Type I Interferon Promote Extrafollicular B Cell Responses to Extracellular Self-DNA

Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus

Molecular Mechanisms Behind the Role of Plasmacytoid Dendritic Cells in Systemic Sclerosis

A type I interferon regulatory network for human plasmacytoid dendritic cells based on heparin, membrane-bound and soluble BDCA-2

Integrin αvβ3 Limits Cytokine Production by Plasmacytoid Dendritic Cells and Restricts TLR-Driven Autoimmunity

Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide

The role of plasmacytoid dendritic cells (pDCs) in immunity during viral infections and beyond

Dendritic Cells in Autoimmune Disease

Dendritic Cells in Systemic Lupus Erythematosus: from Pathogenic Players to Therapeutic Tools.

Update on the role of plasmacytoid dendritic cells in inflammatory/autoimmune skin diseases

Pdc: from Plasmacytoid Dendritic Cell Precursorsto Professional Type 1 Interferon‐producing Cells

Toll-like receptors matter: plasmacytoid dendritic cells in COVID-19

Modulation of plasmacytoid dendritic cells response in inflammation and autoimmunity

Fueling Autoimmunity: Type I Interferon in Autoimmune Diseases.